Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis
- PMID: 33661460
- PMCID: PMC7929907
- DOI: 10.1007/s12020-021-02649-6
Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis
Abstract
Adrenal insufficiency (AI) is a life-threatening condition requiring life-long glucocorticoid (GC) substitution therapy, as well as stress adaptation to prevent adrenal crises. The number of individuals with primary and secondary adrenal insufficiency in Europe is estimated to be 20-50/100.000. A growing number of AI cases are due to side effects of GC treatment used in different treatment strategies for cancer and to immunotherapy in cancer treatment. The benefit of hormone replacement therapy is evident but long-term adverse effects may arise due to the non-physiological GC doses and treatment regimens used. Given multiple GC replacement formulations available comprising short-acting, intermediate, long-acting and novel modified-release hydrocortisone as well as subcutaneous formulations, this review offers a concise summary on the latest therapeutic improvements for treatment of AI and prevention of adrenal crises. As availability of various glucocorticoid formulations and access to expert centers across Europe varies widely, European Reference Networks on rare endocrine conditions aim at harmonizing treatment and ensure access to specialized patient care for individual case-by-case treatment decisions. To improve the availability across Europe to cost effective oral and parenteral formulations of hydrocortisone will save lives.
Keywords: Adrenal crisis; Adrenal insufficiency; Congenital adrenal hyperplasia; Glucocorticoid replacement; Hydrocortisone; Stress instructions.
Conflict of interest statement
N.R. is PI of the Chronocort® Phase III and extension study and of the EU-AIR SHP617-400-P40012 study. The other authors report no conflicts of interest in this work.
Figures



Similar articles
-
European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy.BMC Endocr Disord. 2014 May 9;14:40. doi: 10.1186/1472-6823-14-40. BMC Endocr Disord. 2014. PMID: 24884782 Free PMC article.
-
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion.J Endocrinol Invest. 2020 May;43(5):683-696. doi: 10.1007/s40618-019-01146-y. Epub 2019 Nov 26. J Endocrinol Invest. 2020. PMID: 31773582
-
Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments.Curr Med Res Opin. 2014 Sep;30(9):1833-47. doi: 10.1185/03007995.2014.925865. Epub 2014 Jun 9. Curr Med Res Opin. 2014. PMID: 24849526 Review.
-
Approach to the Child and Adolescent With Adrenal Insufficiency.J Clin Endocrinol Metab. 2025 Feb 18;110(3):863-872. doi: 10.1210/clinem/dgae564. J Clin Endocrinol Metab. 2025. PMID: 39155058 Free PMC article. Review.
-
Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe.Eur J Endocrinol. 2013 Oct 21;169(6):R165-75. doi: 10.1530/EJE-13-0450. Print 2013 Dec. Eur J Endocrinol. 2013. PMID: 24031090 Free PMC article. Review.
Cited by
-
Clinical Manifestations and Challenges in Adolescent and Adult Females With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.J Clin Endocrinol Metab. 2025 Jan 21;110(Supplement_1):S37-S45. doi: 10.1210/clinem/dgae696. J Clin Endocrinol Metab. 2025. PMID: 39836618 Free PMC article. Review.
-
Long-Term Follow-Up of Three Family Members with a Novel NNT Pathogenic Variant Causing Primary Adrenal Insufficiency.Genes (Basel). 2022 Apr 20;13(5):717. doi: 10.3390/genes13050717. Genes (Basel). 2022. PMID: 35627102 Free PMC article.
-
Adrenal crises in adolescents and young adults.Endocrine. 2022 Jun;77(1):1-10. doi: 10.1007/s12020-022-03070-3. Epub 2022 May 18. Endocrine. 2022. PMID: 35583847 Free PMC article. Review.
-
Adrenal trauma experience at a major tertiary centre in Sweden: Clinical and radiological findings.Clin Endocrinol (Oxf). 2022 Jul;97(1):28-35. doi: 10.1111/cen.14697. Epub 2022 Feb 27. Clin Endocrinol (Oxf). 2022. PMID: 35174528 Free PMC article.
-
Complete heart block revealing adrenal tuberculosis.Radiol Case Rep. 2023 Mar 7;18(5):1856-1861. doi: 10.1016/j.radcr.2023.01.096. eCollection 2023 May. Radiol Case Rep. 2023. PMID: 36926541 Free PMC article.
References
-
- F. de Vries, M. Bruin, D.J. Lobatto, O.M. Dekkers, J.W. Schoones, W.R. van Furth, A.M. Pereira, N. Karavitaki, N.R. Biermasz, A.H. Zamanipoor Najafabadi, Opioids and their endocrine effects: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 105(3) (2020). 10.1210/clinem/dgz022 - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous